logo

ICCM

IceCure Medical·NASDAQ
--
--(--)
--
--(--)
1.10 / 10
Underperform

The stock displays challenging fundamental strength (1.1/10). Encouraging metrics: Net profit attributable to parent company shareholders / Net profit (%) and Cash-UP, though challenges appear in Net income-Revenue and Cash-MV. This profile warrants a selective stance.

Fundamental(1.1)SentimentTechnical

Analysis Checks(4/10)

Revenue-MV
Value-2.66
Score2/3
Weight-0.29%
1M Return0.09%
ROA (%)
Value-78.19
Score0/3
Weight16.56%
1M Return-7.78%
Net profit attributable to parent company shareholders / Net profit (%)
Value100.00
Score2/3
Weight5.56%
1M Return-1.71%
Net income-Revenue
Value-0.17
Score1/3
Weight7.85%
1M Return-2.55%
Cash-UP
Value-0.06
Score2/3
Weight13.56%
1M Return-4.86%
Annualized net profit margin on total assets (%)
Value-104.25
Score0/3
Weight16.56%
1M Return-7.78%
Interest coverage ratio (EBIT / Interest expense) (%)
Value15.48
Score2/3
Weight6.27%
1M Return-1.95%
Asset-MV
Value-0.50
Score0/3
Weight10.51%
1M Return-3.57%
Cash-MV
Value-0.07
Score1/3
Weight14.90%
1M Return-5.64%
Net profit / Total profit (%)
Value100.00
Score1/3
Weight8.51%
1M Return-2.89%
Is ICCM undervalued or overvalued?
  • ICCM scores 1.10/10 on fundamentals and holds a Premium valuation at present. Backed by its -133.41% ROE, -513.95% net margin, -2.61 P/E ratio, 4.37 P/B ratio, and 7.14% earnings growth, these metrics solidify its Underperform investment rating.